Multiphasic MR ≠ DR [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2012-03-09 13:18 (5212 d 07:55 ago) – Posting: # 8241
Views: 28,084

Dear Luv!

❝ Does that mean that the same would be applicable to Dexlansoprazole DR capsules as well???


No. This is a delayed release formulation.

❝ What about varying rate of gastric emptying??

❝ We have done a few studies on the said molecule and the first peak comes at 3 hr (range 30 min to 5 hrs and second at 6 hrs (3-8 hrs) and the main reason was varying gastric emptying??


Not uncommon for PPIs. Sometimes physiology plays havoc with formulations.

❝ Then what should be the cut off time????

❝ You fix any cut off time and you will surely fail for partial AUC!!!!


No cut-off, no pAUCs. See the guidance – only conventional FDA's metrics: AUC0-t, AUC0-∞, Cmax. If you are able to show high variability in a replicate design study you are allowed to scale (both AUCs and Cmax).
AFAIK FDA has issued only two product specific guidances for “pAUC BE Metrics for Multiphasic MR Formulations”: zolpidem ER tablets and methylphenidate ER capsules.

❝ Life of a generic scientist is getting tougher day by day!!!!!


Well, I consider myself an ‘original scientist’. ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
136 visitors (0 registered, 136 guests [including 14 identified bots]).
Forum time: 22:13 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5